In summary, we found deregulated expression of TLR6 with a concomitantly activated downstream TLR2/TLR6 activity towards the expression of pro-inflammatory cytokines in peripheral blood cells and in hepatocytes from obesity-related NAFLD patients. Here, TLR6 is linked to metabolic dysfunction-associated steatotic liver disease.